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PCR technology offers alternatives to conventional diagnosis of Cryptosporidium for both clinical and
environmental samples. We compared microscopic examination by a conventional acid-fast staining procedure
with a recently developed PCR test that can not only detect Cryptosporidium but is also able to differentiate
between what appear to be host-adapted genotypes of the parasite. Examinations were performed on 511 stool
specimens referred for screening on the basis of diarrhea. PCR detected a total of 36 positives out of the 511
samples, while routine microscopy detected 29 positives. Additional positives detected by PCR were eventually
conﬁrmed to be positive by microscopy. A total of ﬁve samples that were positive by routine microscopy at
Western Diagnostic Pathology but negative by PCR and by microscopy in our laboratory were treated as false
positives. Microscopy therefore exhibited 83.7% sensitivity and 98.9% speciﬁcity compared to PCR. PCR was
more sensitive and easier to interpret but required more hands-on time to perform and was more expensive
than microscopy. PCR, however, was very adaptable to batch analysis, reducing the costs considerably. Bulk
buying of reagents and modiﬁcations to the procedure would decrease the cost of the PCR test even more. An
important advantage of the PCR test, its ability to directly differentiate between different Cryptosporidium
genotypes, will assist in determining the source of cryptosporidial outbreaks. Sensitivity, speciﬁcity, ability to
genotype, ease of use, and adaptability to batch testing make PCR a useful tool for future diagnosis and studies
on the molecular epidemiology of Cryptosporidium infections.
Cryptosporidium is a protozoan parasite that is ubiquitous in
its geographic distribution and range of vertebrate hosts (16).
Transmission of the parasite is direct, by either the fecal-oral
route or the contamination of water supplies with the resistant
infective oocyst stage of the life cycle. In humans and many
other mammals, Cryptosporidium is recognized as a signiﬁcant
pathogen, primarily as a cause of acute, severe diarrheal ill-
ness. It is also one of the few parasitic infections that is be-
coming more prevalent, and outbreaks, which are now com-
mon (12), may vary in size from a few individuals to several
hundred thousand (10).
Conventional methods for identiﬁcation include examina-
tion of fecal smears with acid-fast stains such as Ziehl-Neelsen
(18), which are commonly used by diagnostic facilities. Con-
ventional microscopy, however, is time-consuming and tedious
and requires experienced microscopists to accurately identify
the oocysts (5, 8). In addition, the detection limits of conven-
tional diagnostic techniques have been reported to be as low as
50,000 to 500,000 oocysts per gram of feces (19). Immunolog-
ically based detection methods have been developed for use in
both clinical and environmental monitoring. However, anti-
genic variability within clinical isolates of Cryptosporidium (6)
can result in some infections remaining undetected, and there
are conﬂicting reports as to the sensitivity of immunodetection
methods over microscopy (1, 8).
Recent research has demonstrated that humans are suscep-
tible to infection with at least two distinct, apparently host-
adapted genotypes of Cryptosporidium (human and calf) (3,
15). Diagnostic tests which can differentiate between human
and animal isolates of Cryptosporidium will therefore be of
particular beneﬁt in outbreak situations such as that in British
Columbia (2), in which determination of the source of infec-
tion is important in limiting transmission. As part of our ac-
tivities at the World Health Organisation Collaborating Centre
(WHO CC) for the Molecular Epidemiology of Parasitic In-
fections, we have recently developed sensitive PCR primers for
the diagnosis of Cryptosporidium (15) which directly differen-
tiate between human and bovine genotypes of C. parvum on
the basis of the size of the PCR product. The aim of this study
was to compare PCR detection of Cryptosporidium with con-
ventional microscopic detection of Cryptosporidium in order to
determine the usefulness and practicality of PCR-based detec-
tion methods for clinical diagnosis of Cryptosporidium.
MATERIALS AND METHODS
Specimens. Fecal samples collected from individuals referred by general prac-
titioners to Western Diagnostic Pathology for testing for enteric parasites were
used in the study. A total of 511 fecal samples were included in this trial.
Specimens were tested blindly by Western Diagnostic Pathology and the labo-
ratories of WHO CC at Murdoch University in appropriately sized batches for
each procedure. Fecal samples were stored at 4°C without preservatives and were
processed within 1 to 2 weeks.
Microscopy. Microscopic diagnosis of Cryptosporidium was performed by
Western Diagnostic Pathology with a cold Ziehl-Neelsen stain. Brieﬂy, a drop of
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995fecal suspension was placed on a glass slide and spread to form a thin smear
(similar to a blood ﬁlm). Slides were ﬁxed in absolute alcohol for 10 min and then
ﬂooded with carbol fuchsin for 1 h. Following washing, the slides were decolor-
ized in 3% acid-alcohol for between 15 s and 1 min, depending on the ﬁlm
thickness. Slides were then washed, counterstained with 1% methylene blue for
4 min, washed and air dried, and examined under 203 and 403 objectives. One
slide was reviewed per patient at a rate of 5 min per slide.
PCR detection. PCR diagnosis of Cryptosporidium was performed at Murdoch
University. Fecal samples were diluted 1 in 4 in phosphate-buffered saline, and
20 ml of this suspension was used for total DNA extraction. A modiﬁcation of a
previously described fecal extraction procedure (15) was employed. Brieﬂy, 20 ml
of the fecal suspension was added to 80 ml of 10% polyvinylpolypyrrolidone
(PVPP) (Sigma, St. Louis, Mo.) in distilled water and boiled for 10 min (PVPP
was added because previous experience in our laboratory has shown that it
reduces PCR inhibition). This solution was spun for 30 s, and the supernatant
was added to a tube containing 200 ml of Al buffer (Qiagen, Hilden, Germany)
and 10 ml of glassmilk (Bio-Rad, Richmond, Calif.). The sample was vortexed,
incubated at 72°C for 5 min, and spun for 1 min, and the pellet was washed twice
with 700 ml of AW wash buffer (Qiagen). The pellet was then vacuum dried, and
the DNA was eluted by adding 50 ml of AE elution buffer (Qiagen), incubating
the solution at 72°C for 10 min, spinning for 1 min, and transferring the super-
natant to a fresh tube. A 2.5-ml aliquot of the eluate was used for PCR analysis.
The primers used in this study had previously been extensively tested for spec-
iﬁcity and sensitivity (15). PCR ampliﬁcation conditions were as previously de-
scribed (15). Duplicate reactions were run for each sample, one consisting of the
test sample and a second reaction mixture containing the test DNA which was
spiked with Cryptosporidium DNA in order to rule out PCR inhibition. A mo-
lecular mass ladder (100-bp; Gibco BRL) and positive and negative controls were
used for each batch run.
RESULTS
A total of 511 fecal samples were screened by both micros-
copy and PCR (Table 1). All 511 fecal samples spiked with
positive control Cryptosporidium DNA ampliﬁed the correct-
sized band, indicating that PCR inhibition was not a factor in
this trial. PCR analysis identiﬁed a total of 36 positives (7% of
the test samples). Microscopy detected a total of 29 positives
(5.6%) of the 36 identiﬁed by PCR. Repeat microscopy in our
WHO CC laboratory on PCR-positive but microscopy-nega-
tive samples eventually revealed them to be positive by micros-
copy, although in a number of cases up to seven slides were
screened at a rate of 10 min per slide before Cryptosporidium
oocysts were detected. Routine microscopy at Western Diag-
nostic Pathology detected ﬁve additional positives which were
negative by PCR and by microscopy in our laboratory and were
considered false positives. Microscopy therefore showed
83.7% sensitivity and 98.9% speciﬁcity compared to 100% sen-
sitivity and speciﬁcity for PCR (Table 1). The PCR test was
also able to directly differentiate between human and calf Cryp-
tosporidium genotypes. Six of the 36 positives displayed the calf
genotype (approximately 17%), and the remaining 30 samples
displayed the human genotype.
The preparation of each slide and the performance of the
acid-fast stain procedure required about 10 min of a technol-
ogist’s time. The reading of the slide required an additional 5
min. Interpretation of the acid-fast stain requires considerable
expertise on the part of the operator. The cost of reagents per
test for the acid-fast stain was very low, approximately $0.30.
The cost of technicians’ time at a rate of 5 min per slide must
be also factored into this ﬁgure, and microscopy is not ame-
nable to bulk processing, as the technologist is required to
spend a minimum of 5 min per slide irrespective of the number
of samples to be screened. The cost per test, including controls
for the PCR procedure, was approximately $2.57; however,
technologist time would add considerably to these costs (Table
2). The extraction of total DNA, PCR ampliﬁcation, and sub-
sequent gel analysis required a total of 4.5 h for a single sample
plus controls; however, only about1ho fthis time was
hands-on time for the technologist. PCR analysis is particularly
amenable to bulk processing, and 96 samples can easily be
processed in 1 to 2 days. Interpretation of the PCR test was
easy, as it was based simply on the presence or absence of a
band and the size of the band denoted the genotype of the
isolate detected. With large throughput processing (96 sam-
ples/batch), the cost per PCR test was reduced to $1.20. A
period of approximately two working days was required to
process 96 samples, with approximately 11 to 12 h of technician
time, although this time could be greatly reduced with improve-
ments to the technique and the use of robotic workstations.
DISCUSSION
We compared conventional microscopy with acid-fast stain-
ing with a recently developed PCR test (15) for the detection
of Cryptosporidium and found microscopy to be considerably
less sensitive and less speciﬁc than PCR analysis. The PCR test
was compared with microscopy instead of with more recently
developed immunological methods for a number of reasons.
Firstly, microscopical analysis of stained fecal smears is the
most widely used method for screening stool samples for Cryp-
tosporidium in clinical diagnostic laboratories. Secondly, previ-
ous research has shown that immunologically based detection
methods are not signiﬁcantly more sensitive than conventional
microscopy (8, 17). In addition, because of differences in the
interpretation of results obtained with immunologically based
detection methods, as well as antigenic variability of clinical
isolates of Cryptosporidium (6), microscopy was considered to
be a more reliable diagnostic tool for the purposes of this
comparative trial.
Because it is sensitive and easy to use, PCR ampliﬁcation is
an obvious choice for improved detection of Cryptosporidium
from feces. However, fecal constituents such as bilirubin, bile
salts, and complex polysaccharides inhibit PCR even when they
are present at low concentrations (13, 21). We have therefore
developed a simple, fast, and low-cost extraction technique
which appears to eliminate most PCR inhibitors present in
human feces from the template DNA. We initially tested
PVPP, as it had been shown by another group at Murdoch to
be useful in removing PCR inhibition in ampliﬁcations of fungi
TABLE 1. Comparison of PCR versus microscopic detection
of Cryptosporidium
Method
No. of
samples
examined
No. of
positives
detected
Sensitivity
(%)
a
Speciﬁcity
(%)
b
Strain
discrimination
PCR 511 36
c 100 100 Yes
c
Microscopy 511 29 83.7 98.9 No
a Calculated as follows: [number of true positives/(number of true positives 1
number of false negatives)] 3 100.
b Calculated as follows: [number of true negatives/(number of true negatives 1
number of false positives)] 3 100.
c The PCR test was able not only to detect Cryptosporidium oocysts but also to
identify isolate genotypes (15). Of the 36 positives detected in the present study,
30 were of the human genotype and 6 were of the calf genotype.
TABLE 2. Cost of PCR versus microscopy for the detection
of Cryptosporidium
Method
Reagent costs ($/test) for: Technologist
time (min)
a
Single test Batch test
b
Microscopy 0.30 0.15 15
PCR 2.57 1.20 60
a Time is for a single test plus controls.
b Ninety-six tests per batch.
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found to be necessary, as without this step approximately 30%
of samples exhibited PCR inhibition (data not shown). Simply
diluting the template DNA was not sufﬁcient in all cases and
resulted in a reduction of the sensitivity of the assay. A com-
mercially available glassmilk (Bio-Rad) was used in this trial,
although it has recently been shown that silica which is of
deﬁned size is at least 1,000 times less expensive and as effec-
tive as glassmilk quantitatively and qualitatively for purifying
plasmid DNA minipreps and recovering fragments from aga-
rose gels (4). Therefore, a 100-mg/ml suspension of silica (Sig-
ma) in 3 M sodium iodide (4) would be an inexpensive and
effective alternative to glassmilk.
A variety of PCR primers have been developed for the
detection of Cryptosporidium in both fecal and environmental
samples (14). Few of these primers, however, have been tested
on large numbers of clinical or environmental samples or com-
pared with conventional detection methods. In one study PCR
was compared with immunoﬂuorescent (IF) antibodies for the
detection of Cryptosporidium in water samples (7); due to a
number of problems, including inhibition, PCR was no more
sensitive than immunoﬂuorescence for the detection of Cryp-
tosporidium. In another study (11), nested PCR was compared
with IF staining, but discrepancies were reported between the
two techniques because of PCR inhibition and also presumably
because of the antibody binding to empty oocysts which are
found routinely in water concentrates (9). In a more recent
study, PCR was compared with both auramine phenol and IF
staining in bovine feces (20). Immunomagnetic separation was
used to purify the oocysts for PCR analysis, and PCR was
reported to be several orders of magnitude more sensitive than
conventional techniques. However, the test was performed on
seeded feces from a limited number of cattle, and when PCR
is coupled with immunomagnetic separation, the associated
problems with antibody detection, particularly cross-reactivity
and antigenic variability between isolates, are reintroduced (6).
Microscopy was cheaper to perform than PCR, but the cost
of PCR detection was greatly reduced when a large number of
samples was analyzed. With large throughput processing (96
samples/batch), the cost per test was reduced to $1.20. PCR is
particularly amenable to automation and large throughput
processing, and with bulk buying of reagents and modiﬁcations
to the technique to reduce hands-on time, such as the use of
96-well plates for PCR setup and ampliﬁcation, this cost could
easily be further substantially reduced, thereby making PCR a
more attractive option ﬁnancially. In this trial, two PCRs were
set up for each sample: a test sample and a second sample
spiked with Cryptosporidium DNA in order to rule out PCR
inhibition. However, a nonhomologous internal control could
easily be constructed with commercially available kits such as
the PCR mimic construction kit (Clontech, Palo Alto, Calif.),
which would result in the ampliﬁcation of a different-sized
band with the Cryptosporidium diagnostic primers. This inter-
nal control could then be used to monitor the success of each
PCR and would reduce the assay to a one-tube test, thus
rendering it more cost-effective.
For clinical as well as environmental laboratories, both the
ability to detect pathogens reliably and the ability to determine
the numbers of pathogens present are important. Quantitative
PCR techniques such as the Taqman LS-50B PCR detection
system (Perkin-Elmer, Foster City, Calif.) have recently been
launched, and the test described in the present study could be
developed into a quantitative PCR test with this technology;
however, the cost of the assay would be signiﬁcantly higher.
Because of its sensitivity, the assay described in this study
has the potential for accurate diagnosis in patients who do not
presently know the reason for their diarrhea. This will have
considerable advantages in the treatment of immunosup-
pressed individuals, allowing early diagnosis before the onset
of symptoms. In addition, this PCR test is capable of directly
differentiating between human- and animal-derived genotypes
of Cryptosporidium on the basis of the size of the PCR product
(15). The potential for zoonotic transmission from livestock
and wild-animal reservoirs via environmental contamination is
of increasing concern. Thus, the primers used in this study may
be valuable in the predictive epidemiology of cryptosporidial
infections in humans and livestock.
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